High-risk Smoldering Multiple Myeloma

Explore clinical trials studying High-risk Smoldering Multiple Myeloma. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

High-risk Smoldering Multiple Myeloma trial results

Recruiting

NCT05469893

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Colorado Blood Cancer Institute Denver, Colorado, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Oregon Health & Science University Portland, Oregon, United States

Completed

NCT01484275

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Chicago, Illinois, United States

Rockville, Maryland, United States

Detroit, Michigan, United States

New York, United States

View all 40 locations

Active, Not Recruiting

NCT04775550

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Stamford Hospital Stamford, Connecticut, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Dana-Farber Brigham Cancer Center - Foxborough Foxborough, Massachusetts, United States